주식/증권 📈 긍정적

Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now

Yahoo Finance 09/04/2026 01:58:00 PM 5회

요약

NPCE's RNS adoption, reimbursement gains, referral expansion and AI tools support growth, while IGE delays and higher spending pressure profitability.

원문 기사 보기

관련 뉴스

US stock futures rise tracking oil price decline; Q3 earnings on tap

10/12/2026

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

10/12/2026

Sector rotation reveals new buying opportunities (even with the S&P 500 near record highs)

10/12/2026

Which Global Real Estate ETF Is the Better Buy: State Street’s RWO or Xtrackers’ HAUZ?

10/12/2026

뉴스 목록으로